Device closure of PFO remains a relatively controversial topic in those with otherwise normal hearts. In this patient population.
KeywordsAntiplatelet Therapy Device Closure Tunnel Length Residual Shunt Transient Ischemic Attack
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- Mullen MJ, Hildick-Smith D, De Giovanni JV et al. BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation. 2006;114:1962-1967.PubMedCrossRefGoogle Scholar
© Springer Science+Business Media, LLC 2009